Additional transplantation of ex vivo generated megakaryocytic cells after high-dose chemotherapy

Haematologica

Volumn 89, Issue 5, 2004, Pages 630-631

  Scheding, Stefan ^a,c   Bergmannn, Markus ^a   Rathke, Gisa ^a   Vogel, Wichard ^a   Brugger, Wolfram ^a,b   Kanz, Lothar ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b SCHWARZWALD BAAR KLINIKUM   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

CD34+ hematopoietic progenitor cells; Ex vivo expansion; High dose chemotherapy; Megakaryocytic cells; Peripheral blood progenitor cell transplantation

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; THIOTEPA;

APHERESIS; ARTICLE; BONE MARROW CULTURE; CANCER CHEMOTHERAPY; CASE REPORT; CRYOPRESERVATION; CYTOPENIA; DRUG MEGADOSE; EX VIVO STUDY; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; MEGAKARYOCYTE; SAFETY; SOLID TUMOR; THROMBOCYTE;

ANTIGENS, CD34; ANTINEOPLASTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MEGAKARYOCYTES; PILOT PROJECTS; TRANSPLANTATION, AUTOLOGOUS; TUMOR CELLS, CULTURED;

EID: 2542494072     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. + cells. Lancet 1999; 354:1092-3.
2. McNiece I, Jones R, Bearman SI, Cagnoni P, Nieto Y, Franklin W, et al. Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer. Blood 2000;96:3001-7.
3. + cells with stem cell factor (SCF) and promegapoietin (PMP). Exp Hematol 2000; 28:335-46.
4. + cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin. Blood 1994;84:1421-6.
5. Bokemeyer C, Franzke A, Hartmann JT, Schober C, Arseniev L, Metzner B, et al. A phase I/II study of sequential, dose-escalated, high dose ifosfamide plus doxorubicin with peripheral blood stem cell support for the treatment of patients with advanced soft tissue sarcomas. Cancer 1997;80:1221-7.
6. + progenitor cells. Exp Hematol 2000;28:460-70.
7. Bertolini F, Battaglia M, Pedrazzoli P, Da PG, Lanza A, Soligo D, et al. Megakaryocytic progenitors can be generated ex vivo and safely administered to autologous peripheral blood progenitor cell transplant recipients. Blood 1997;89:2679-88.